immunologic mechanism

im·mu·no·log·ic mech·a·nism

the groups of cells (chiefly lymphocytes and cells of the reticuloendothelial system) that function in establishing acquired immunity (induced sensitivity, allergy).
References in periodicals archive ?
The proposed immunologic mechanism for the development of human diabetes after infant exposure to nonpharmacological amounts of bovine insulin could be extended to bovine growth hormone.
com), a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on the immunologic mechanism of action of PV-10, presented at the 2012 Society of Surgical Oncology Annual Meeting, confirms that PV-10 chemoablation of melanoma lesions leads to a systemic response and the induction of systemic anti-tumor immunity.
Agarwala continued, "I look forward to being part of a research team being assembled to begin investigating the immunologic mechanism of action underlying these results through an anticipated Phase 2B clinical study.
The immunopathogenesis of food allergies may be governed by more than one immunologic mechanism, including immediate manifestations mediated by IgE; inflammatory reactions caused by immune complexes, lectins, and superantigens; and delayed hypersensitivity reactions associated with specific T lymphocytes (Helm and Burks 2000).
com), a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on the immunologic mechanism of action of PV-10, presented at the Society of Surgical Oncology Annual Meeting, confirms that PV-10 chemoablation of melanoma lesions induces a systemic response that can lead to regression of synchronous lung metastases or synchronous subcutaneous melanoma.
Direct infection of the kidneys or an immunologic mechanism may have been the underlying cause.
Although the association of Guillain-Barre syndrome and temporal arteritis in these three patients could be coincidental, a common immunologic mechanism is also a possibility.
com), a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on the immunologic mechanism of action of PV-10 will be presented at the Society of Surgical Oncology Annual Meeting, March 21-24, 2012, at the Orlando World Center Marriott in Orlando, Florida.
A Phase 2B clinical study is in the process of being designed to investigate the immunologic mechanism of action underlying the apparent immunologic response that PV-10 chemoablation can elicit against untreated lesions.
Agarwala also discussed plans to conduct research into PV-10's immunologic mechanism of action.
Optiquel[TM] therapy is based on oral tolerance, an immunologic mechanism that down-regulates immune responses in an antigen-specific manner, rather than a non-specific immunosuppressive approach.
At these sites, investigators will study the immunologic mechanism of the column, using patient blood samples available from the clinical study.